Kentucky Access to Recovery Evaluation

Evaluate the long-term effectiveness of implementing vouchers as a linkage strategy in a population requiring recovery support services (RSS) when no other funding sources are available. A within-subjects study design will be used to test the effectiveness of the Kentucky Access to Recovery (KATR) last resort voucher linkage approach to reduce the risk of nonfatal and fatal overdoses by (a) increasing an individual's recovery capital; (b) reducing resumption of illicit substance use; and (c) promoting relinking to RSSs if illicit substance use is resumed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders Behavior Behavior, Addictive Chemically-Induced Disorders Compulsive Behavior Drug Misuse Drug Overdose Health Behavior Impulsive Behavior Mental Disorders Narcotic-Related Disorders Opiate Overdose Opioid-Related Disorders Prescription Drug Misuse Substance-Related Disorders Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

FAHE, Berea, Kentucky, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

be in SUD treatment or have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use
be a first-time participant in KATR
be in early stages of recovery (less than one year in recovery)
be a resident of a KATR service county
be at or below the 200% federal poverty level
not have financial resources available through other funding mechanisms for RSSs
be 18 years of age and older
be in need of recovery supports that will enhance their likelihood of staying in recovery

Exclusion criteria

Under 18
Participated in KATR previously

Treatment and study plan

KATR Linkage Strategy

Behavioral

The Kentucky ATR (KATR) strategy is a 25-county program that links county residents at or below the 200% national poverty level who have an illicit SUD and are in treatment or early recovery to evidence-based RSSs such as recovery housing, and to other RSSs.

The KATR linkage approach uses vouchers as a linkage strategy for individuals in SUD treatment who have no other funding options to acquire critical RSSs. As such, KATR's linkage through vouchers is a "last resort" approach for linking to RSSs.

Primary outcomes

Change in Recovery Capital per person

Time frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment

Recovery capital will be assessed using the Brief Assessment of Recovery Capital-10 (BARC-10); 10 item survey unidimensional measure of recovery capital, scores may range from 6-60 at any given time. Evaluation of the measure suggests that individuals who have a higher score are likely to reach or sustain a year or longer of recovery from substance use disorder.
Change in number of drug overdoses per person

Time frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment

Number of drug overdoses will be assessed with the following survey question: In the past 30 days, did you experience an overdose or take too much of a substance that resulted in needing supervision or medical attention?
Change in number of days of illicit substance use per person

Time frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment

Number of days illicit substance use will be assessed with the following survey question: During the past 30 days, how many days have you used any substance

Sponsors and collaborators

Lead sponsor

Terry Bunn

Other

Registry information

Official study title

Evaluation of the Kentucky Access to Recovery (KATR) Linkage Strategy

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Jun 5, 2023
Registry last updated: Apr 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed